| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282867 | Clinical Gastroenterology and Hepatology | 2012 | 7 Pages |
Abstract
The combination of midodrine and octreotide after LVP is not superior to albumin in delaying recurrence of ascites or preventing PCD in patients with cirrhosis. Outcomes appear to be worse in patients given octreotide and midodrine. ClinicalTrials.gov number, NCT00108355.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Khurram Bari, Cecilia Miñano, Martha Shea, Irteza B. Inayat, Hashem J. Hashem, HoChong Gilles, Douglas Heuman, Guadalupe Garcia-Tsao,